The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.
As the world becomes more connected, collaboration and cooperation are needed to reduce the impact of future epidemics.To reduce the risk of future epidemics, increasing research is being conducted across the globe.
For instance, the National Institutes of Health (US) invests USD 40 billion annually in health innovation and is expected to spend billions more on COVID- 19 research. Similarly, the UK government has decided to increase its R&D spending over the next three years to reach USD 28.82 billion (GBP 22 billion) by 2024–25. Countries in Asia, such as China and India, have also increased investments in their healthcare and pharmaceutical sectors.
The instruments segment will grow at the highest rate during the forecast period. On the basis ofproduct, the nucleic acid isolation and purification market is segmented intokits, reagents, and instruments.In 2021, kits were the largest product segment in the market.
Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.
By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021. On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation andpurification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
The market in the Asia Pacificis projected to witness the highest growth rate during the forecast period (2020–2027). North America accounted for the largest share of the nucleic acid isolation and purification market in 2021.Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America.
On the other hand, the Asia Pacificis projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.
A breakdown of the primary participants referred to for this report is provided below: • By Company Type (Supply-side): Tier 1(29%), Tier 2(37%), and Tier 3(34%) • By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals& Diagnostic Centers (30%), and Academic &Government Research Institutes (22%), and Other End Users (10%) • By Designation: C-level(37%), Director-level(23%), and Managers(40%) • By Region: North America(37%), Europe(30%), Asia Pacific(21%), and the RoW(12%)
QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GEHealthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
Research Coverage: The report analyzes the nucleic acid isolation and purification market and aims at estimating themarket size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.
Reasons to Buy the Report The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one, or a combination of the belowmentioned five strategies.
This report provides insights into the following pointers: • Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutionsacross regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.
Our reports have been used by over 10K customers, including:
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Genomics Proteomics And Enabling Technology
Infectious Disease Incidence
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.